Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Poliquin

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
The Yale Journal of Biology and Medicine|September 1, 1990
Post-bone marrow transplant patient managementC M Poliquin
Clinical Journal of Oncology Nursing|January 1, 1997
Overview of bone marrow and peripheral blood stem cell transplantationC M Poliquin
The Canadian Journal of Medical Radiation Technology|July 7, 1994
Competency-based certification project. Phase I: Job analysisM E Gessaroli, M Poliquin
The Canadian Journal of Medical Radiation Technology|February 7, 1995
Competency-Based Certification Project. Phase III: content validity, standard setting and criterion-related validityM E Gessaroli, M Poliquin
The Canadian Journal of Medical Radiation Technology|September 5, 1994
Competency-Based Certification Project. Phase II: Examination blueprintM E Gessaroli, M Poliquin
L'Union Medicale Du Canada|October 1, 1985
[Diet and intensive insulin therapy]C Robillard, M Poliquin, D Lopez, et al.
Diabetes Care|July 1, 1984
Continuous subcutaneous insulin infusion (Mill-Hill Infuser) versus multiple injections (Medi-Jector) in the treatment of insulin-dependent diabetes mellitus and the effect of metabolic control on microangiopathyJ L Chiasson, F Ducros, M Poliquin-Hamet, et al.
Gastroenterology|April 1, 1994
The changing scene of hepatic vein thrombosis: recognition of asymptomatic casesA Hadengue, M Poliquin, V Vilgrain, et al.
Gastroenterology|February 13, 2001
Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapyB Condat, F Pessione, S Hillaire, et al.
Hepatology (Baltimore, Md.)|October 1, 1995
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis CM Martinot-Peignoux, P Marcellin, M Pouteau, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
The Yale Journal of Biology and Medicine|September 1, 1990
Post-bone marrow transplant patient managementC M Poliquin
Clinical Journal of Oncology Nursing|January 1, 1997
Overview of bone marrow and peripheral blood stem cell transplantationC M Poliquin
The Canadian Journal of Medical Radiation Technology|July 7, 1994
Competency-based certification project. Phase I: Job analysisM E Gessaroli, M Poliquin
The Canadian Journal of Medical Radiation Technology|February 7, 1995
Competency-Based Certification Project. Phase III: content validity, standard setting and criterion-related validityM E Gessaroli, M Poliquin
The Canadian Journal of Medical Radiation Technology|September 5, 1994
Competency-Based Certification Project. Phase II: Examination blueprintM E Gessaroli, M Poliquin
L'Union Medicale Du Canada|October 1, 1985
[Diet and intensive insulin therapy]C Robillard, M Poliquin, D Lopez, et al.
Diabetes Care|July 1, 1984
Continuous subcutaneous insulin infusion (Mill-Hill Infuser) versus multiple injections (Medi-Jector) in the treatment of insulin-dependent diabetes mellitus and the effect of metabolic control on microangiopathyJ L Chiasson, F Ducros, M Poliquin-Hamet, et al.
Gastroenterology|April 1, 1994
The changing scene of hepatic vein thrombosis: recognition of asymptomatic casesA Hadengue, M Poliquin, V Vilgrain, et al.
Gastroenterology|February 13, 2001
Current outcome of portal vein thrombosis in adults: risk and benefit of anticoagulant therapyB Condat, F Pessione, S Hillaire, et al.
Hepatology (Baltimore, Md.)|October 1, 1995
Pretreatment serum hepatitis C virus RNA levels and hepatitis C virus genotype are the main and independent prognostic factors of sustained response to interferon alfa therapy in chronic hepatitis CM Martinot-Peignoux, P Marcellin, M Pouteau, et al.
Pageof 2